Evidence map›Paper›PMID 37627696›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Synergistic Antibacterial Effects of Amoxicillin and Gold Nanoparticles: A Therapeutic Option to Combat Antibiotic Resistance.

Rosa M Giráldez-Pérez, Elia M Grueso, Alfonso Carbonero, Juan Álvarez Márquez, Mirian Gordillo, Edyta Kuliszewska, Rafael Prado-Gotor

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rosa M Giráldez-PérezDepartment of Cell Biology, Physiology and Immunology, Faculty of Sciences, University of Cordoba, 14014 Cordoba, Spain.ORCID 0000-0002-9495-1047
Elia M GruesoDepartment of Physical Chemistry, Faculty of Chemistry, University of Seville, 41012 Seville, Spain.ORCID 0000-0002-1397-6104
Alfonso CarboneroDepartment of Animal Health, Veterinary Faculty, University of Cordoba, 14014 Cordoba, Spain.ORCID 0000-0002-0569-8714
Juan Álvarez MárquezDepartment of Cell Biology, Physiology and Immunology, Faculty of Sciences, University of Cordoba, 14014 Cordoba, Spain.
Mirian GordilloDepartment of Animal Health, Veterinary Faculty, University of Cordoba, 14014 Cordoba, Spain.
Edyta KuliszewskaChemtra Company, 47-300 Krapkowize, Poland.
Rafael Prado-GotorDepartment of Physical Chemistry, Faculty of Chemistry, University of Seville, 41012 Seville, Spain.ORCID 0000-0001-5959-9810
University of Córdoba · ESUniversidad de Sevilla · ES

Funding

Consejería de Economía, Conocimiento, Empresa y Universidad of Junta de Andalucía 2021/FQM-386University of Seville. VII PP USO SSGG 2022/00000274University of Seville. VII PP USO SSGG 2023/00000303University of Seville. VI PP USO SSGG 2021/00001297
6 · The paper itself

Abstract

Compacted Au@16-mph-16/DNA-AMOX (NSi) nanosystems were prepared from amoxicillin (AMOX) and precursor Au@16-mph-16 gold nanoparticles (Ni) using a Deoxyribonucleic acid (DNA) biopolymer as a glue. The synthesized nanocarrier was tested on different bacterial strains of

Indexed as

amoxicillinantibiotic resistanceaureus nanosystemgemini surfactantgold nanoparticles

Identifiers

PMID37627696
PMCPMC10451730
OpenAlexW4385481448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.